Gara Jalqabaatti › Lupus › North Carolina › Durham
Qorannoo klinikaalii Lupus Durham, NC keessatti
Qorannoo 12 Lupus f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Durham
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Chapel Hill · Miili 10 fagaatti
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Chapel Hill · Miili 10 fagaatti
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · Miili 10 fagaatti
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 1/2
- UNC Chapel Hill, Chapel Hill · Miili 10 fagaatti
Intervention to Improve Communication and Medication Adherence in Lupus
Namoota walitti qabaa jira
- Duke University, Durham
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
- Duke University, Durham
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Health System, Durham
Lupus Landmark Study: A Prospective Registry and Biorepository
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC Chapel Hill, Chapel Hill · Miili 10 fagaatti
Duke Lupus Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Duke University, Durham
Qorannoo Lupus magaalota biroo keessatti
- New York City, NYQorannoo 18
- Houston, TXQorannoo 13
- Washington, DCQorannoo 10
- Miami, FLQorannoo 10
- Tampa, FLQorannoo 9
- Philadelphia, PAQorannoo 9
- Clearwater, FLQorannoo 8
- Santa Monica, CAQorannoo 8
- Oklahoma City, OKQorannoo 8
- Boston, MAQorannoo 8
- Los Angeles, CAQorannoo 8
- Chicago, ILQorannoo 8
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 63
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Kansara MetastatikiiQorannoo 33
- Leukemia Myeloidii HamaaQorannoo 33
- Dhibee QaraQorannoo 32
- Kansarii ProstateQorannoo 32
- Kansarii ColorectalQorannoo 28
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Kansarii OvariiQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.